# EDGAR Filing Document

**Accession Number:** 0001137360
**File Stem:** 0001752724-25-196026
**Filing Date:** 2025-8
**Character Count:** 14168
**Document Hash:** 3015d9e3df181dc6a3ce234eceb1b73b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-25-196026.hdr.sgml**: 20250821

**ACCESSION NUMBER**: 0001752724-25-196026

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250821

**DATE AS OF CHANGE**: 20250821

**PERIOD START**: 20250930

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** VanEck ETF Trust
- **CENTRAL INDEX KEY:** 0001137360

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-10325
- **FILM NUMBER:** 251239214

**BUSINESS ADDRESS:**
- **STREET 1:** 666 THIRD AVENUE, 9TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 212-293-2000

**MAIL ADDRESS:**
- **STREET 1:** 666 THIRD AVENUE, 9TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** VanEck Vectors ETF Trust
- **DATE OF NAME CHANGE:** 20160427

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MARKET VECTORS ETF TRUST
- **DATE OF NAME CHANGE:** 20070312

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MARKET VECTORS TRUST
- **DATE OF NAME CHANGE:** 20050516

## Series and Classes Contracts Data

### VanEck Biotech ETF (Series ID: S000034406)

| Class ID   | Class Name         | Ticker Symbol   |
|:---|:---|:---|
| C000105864 | VanEck Biotech ETF | BBH             |

## Nport-Ex

VANECK

BIOTECH

ETF

SCHEDULE

OF

INVESTMENTS

June

30,

2025

(unaudited)

#### FootnoteRuleAboveBlank

#### Footnotes:

#### Number

#### of

#### Shares

#### Value

#### COMMON

#### STOCKS:

#### 100.0%

#### China

#### :

#### 2.7%
BeOne

Medicines

Ltd.

(ADR) \*

37,119

$

8,985,396

Underline

#### Germany

#### :

#### 3.0%
BioNTech

SE

(ADR) \*

92,384

9,836,125

Underline

#### Ireland

#### :

#### 3.2%
ICON

PLC

(USD) \*

72,849

10,595,887

Underline

#### United

#### States

#### :

#### 91.1%
Alnylam

Pharmaceuticals,

Inc. \*

50,345

16,417,001

Amgen,

Inc.

186,831

52,165,084

Argenx

SE

(ADR) \*

29,049

16,012,390

Biogen,

Inc. \*

90,526

11,369,160

BioMarin

Pharmaceutical,

Inc. \*

91,728

5,042,288

Bio-Techne

Corp.

114,036

5,867,152

Charles

River

Laboratories

International,

Inc. \*

35,239

5,346,814

Exact

Sciences

Corp. \*

97,746

5,194,223

#### Number

#### of

#### Shares

#### Value

#### United

#### States
(continued)

Gilead

Sciences,

Inc.

398,094

$

44,136,682

Illumina,

Inc. \*

104,109

9,933,040

Incyte

Corp. \*

100,301

6,830,498

Insmed,

Inc. \*

119,786

12,055,263

IQVIA

Holdings,

Inc. \*

94,644

14,914,948

Moderna,

Inc. \*

281,324

7,761,729

Natera,

Inc. \*

90,144

15,228,927

Neurocrine

Biosciences,

Inc. \*

74,948

9,420,214

QIAGEN

NV \*

†

119,304

5,733,750

Regeneron

Pharmaceuticals,

Inc.

32,208

16,909,200

Repligen

Corp. \*

36,948

4,595,592

Sarepta

Therapeutics,

Inc. \*

68,551

1,172,222

Vertex

Pharmaceuticals,

Inc. \*

78,661

35,019,877

301,126,054

#### Total

#### Common

#### Stocks
(Cost:

$375,104,477)

330,543,462

#### Total

#### Investments:

#### 100.0%
(Cost:

$375,104,477)

330,543,462

#### Other

#### assets

#### less

#### liabilities:

#### 0.0%
81,072

#### NET

#### ASSETS:

#### 100.0%
$

330,624,534

#### Definitions:
ADR

American

Depositary

Receipt

USD

United

States

Dollar

\*

Non-income

producing

†

Security

fully

or

partially

on

loan.

Total

market

value

of

securities

on

loan

is

$5,160,346.

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** VanEck ETF Trust

- **b. Investment Company Act file number:** 811-10325

- **c. CIK number of Registrant:** 0001137360

- **d. LEI of Registrant:** 549300ZLFKNTXC51ZN76

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 666 THIRD AVENUE, 9TH FLOOR

  - **City:** NEW YORK

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10017

  - **Telephone number:** 212-293-2000

**Item A.2. Information about the Series.**

- **a. Name of Series:** VanEck Biotech ETF

- **b. EDGAR series identifier (if any):** S000034406

- **c. LEI of Series:** 549300PGHG6VYS4R2K51

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-09-30

- **b. Date as of which information is reported:** 2025-06-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $330786774.87

**Total Liabilities:** $162363.46

**Net Assets:** $330624411.41

**Cash Not Reported:** $235152.59

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000105864 | -2.75%               | -2.91%               | 3.23%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $699587.68               | $-11114493.72                              |
| Month 2  | $1297405.78              | $-12074993.21                              |
| Month 3  | $1588683.10              | $8809442.16                                |

### Schedule of Portfolio Investments

| Name                                         | Title                                        | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Charles River Laboratories International Inc | Charles River Laboratories International Inc | CUSIP: 159864107<br>LEI: 549300BSQ0R4UZ5KX287 | Long             | EC               | CORP              | US        |     35239 | NS      | $5346813.47   | 1.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Alnylam Pharmaceuticals Inc                  | Alnylam Pharmaceuticals Inc                  | CUSIP: 02043Q107<br>LEI: 529900S3ZI14OWRJII50 | Long             | EC               | CORP              | US        |     50345 | NS      | $16417001.05  | 4.97%             |  |  |  | No            |                  1 | On Loan: No      |
| BioNTech SE                                  | BioNTech SE                                  | CUSIP: 09075V102<br>LEI: 894500UZJ5LG1F8J1U58 | Long             | EC               | CORP              | DE        |     92384 | NS      | $9836124.48   | 2.98%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals Inc                   | Vertex Pharmaceuticals Inc                   | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |     78661 | NS      | $35019877.20  | 10.59%            |  |  |  | No            |                  1 | On Loan: No      |
| Exact Sciences Corp                          | Exact Sciences Corp                          | CUSIP: 30063P105<br>LEI: 549300VM3X1FYD4N9Z14 | Long             | EC               | CORP              | US        |     97746 | NS      | $5194222.44   | 1.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Repligen Corp                                | Repligen Corp                                | CUSIP: 759916109<br>LEI: 54930006QJ0T5AUO1E71 | Long             | EC               | CORP              | US        |     36948 | NS      | $4595592.24   | 1.39%             |  |  |  | No            |                  1 | On Loan: No      |
| BioMarin Pharmaceutical Inc                  | BioMarin Pharmaceutical Inc                  | CUSIP: 09061G101<br>LEI: NSLL8ITTRR0J5HEMR848 | Long             | EC               | CORP              | US        |     91728 | NS      | $5042288.16   | 1.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Biogen Inc                                   | Biogen Inc                                   | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |     90526 | NS      | $11369160.34  | 3.44%             |  |  |  | No            |                  1 | On Loan: No      |
| IQVIA Holdings Inc                           | IQVIA Holdings Inc                           | CUSIP: 46266C105<br>LEI: 549300W3R20NM4KQPH86 | Long             | EC               | CORP              | US        |     94644 | NS      | $14914947.96  | 4.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Moderna Inc                                  | Moderna Inc                                  | CUSIP: 60770K107<br>LEI: 549300EI6OKH5K5Q2G38 | Long             | EC               | CORP              | US        |    281324 | NS      | $7761729.16   | 2.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Illumina Inc                                 | Illumina Inc                                 | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               | CORP              | US        |    104109 | NS      | $9933039.69   | 3.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Incyte Corp                                  | Incyte Corp                                  | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |    100301 | NS      | $6830498.10   | 2.07%             |  |  |  | No            |                  1 | On Loan: No      |
| ICON PLC                                     | ICON PLC                                     | CUSIP: 000000000<br>LEI: 6354008SRQGEMC4XFI67 | Long             | EC               | CORP              | IE        |     72849 | NS      | $10595887.05  | 3.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc                                    | Amgen Inc                                    | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |    186831 | NS      | $52165083.51  | 15.78%            |  |  |  | No            |                  1 | On Loan: No      |
| Bio-Techne Corp                              | Bio-Techne Corp                              | CUSIP: 09073M104<br>LEI: 54930073RLKQ51TILZ35 | Long             | EC               | CORP              | US        |    114036 | NS      | $5867152.20   | 1.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Sarepta Therapeutics Inc                     | Sarepta Therapeutics Inc                     | CUSIP: 803607100<br>LEI: 549300IKDPIED8J8IG21 | Long             | EC               | CORP              | US        |     68551 | NS      | $1172222.10   | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| QIAGEN NV                                    | QIAGEN NV                                    | CUSIP: 000000000<br>LEI: 54930036WK3GMCN17Z57 | Long             | EC               | CORP              | NL        |    119304 | NS      | $5733750.24   | 1.73%             |  |  |  | No            |                  1 | On Loan: —       |
| Argenx SE                                    | Argenx SE                                    | CUSIP: 04016X101<br>LEI: 7245009C5FZE6G9ODQ71 | Long             | EC               | CORP              | NL        |     29049 | NS      | $16012389.78  | 4.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Insmed Inc                                   | Insmed Inc                                   | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |    119786 | NS      | $12055263.04  | 3.65%             |  |  |  | No            |                  1 | On Loan: No      |
| BeOne Medicines Ltd                          | BeOne Medicines Ltd                          | CUSIP: 07725L102<br>LEI: 549300JFUK6FRD5MH739 | Long             | EC               | CORP              | CH        |     37119 | NS      | $8985396.33   | 2.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Natera Inc                                   | Natera Inc                                   | CUSIP: 632307104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     90144 | NS      | $15228927.36  | 4.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Neurocrine Biosciences Inc                   | Neurocrine Biosciences Inc                   | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |     74948 | NS      | $9420214.12   | 2.85%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals Inc                | Regeneron Pharmaceuticals Inc                | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |     32208 | NS      | $16909200.00  | 5.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc                          | Gilead Sciences Inc                          | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |    398094 | NS      | $44136681.78  | 13.35%            |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-07-30

**Name of Applicant:** VanEck ETF Trust

**Signature:** James Parker

**Name of Signer:** James Parker

**Title:** Assistant Treasurer